These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 18093045

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Incorporating additional biological phenomena into two-stage cancer models.
    Sielken RL, Bretzlaff RS, Stevenson DE.
    Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
    [Abstract] [Full Text] [Related]

  • 3. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW, Crump KS.
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [Abstract] [Full Text] [Related]

  • 4. Hormesis without cell killing.
    Cox LA.
    Risk Anal; 2009 Mar; 29(3):393-400. PubMed ID: 18793280
    [Abstract] [Full Text] [Related]

  • 5. Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and Doll.
    Little MP.
    Biometrics; 1995 Dec; 51(4):1278-91. PubMed ID: 8589222
    [Abstract] [Full Text] [Related]

  • 6. Could removing arsenic from tobacco smoke significantly reduce smoker risks of lung cancer?
    Cox LA.
    Risk Anal; 2009 Jan; 29(1):3-17. PubMed ID: 19000069
    [Abstract] [Full Text] [Related]

  • 7. A search for thresholds and other nonlinearities in the relationship between hexavalent chromium and lung cancer.
    Park RM, Stayner LT.
    Risk Anal; 2006 Feb; 26(1):79-88. PubMed ID: 16492182
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Incorporation of inter-individual heterogeneity into the multistage carcinogenesis model: approach to the analysis of cancer incidence data.
    Izumi S, Ohtaki M.
    Biom J; 2007 Aug; 49(4):539-50. PubMed ID: 17722193
    [Abstract] [Full Text] [Related]

  • 12. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
    Harrison J.
    J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
    [Abstract] [Full Text] [Related]

  • 13. Computer simulation of cell growth governed by stochastic processes: application to clonal growth cancer models.
    Conolly RB, Kimbell JS.
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):284-95. PubMed ID: 8122275
    [Abstract] [Full Text] [Related]

  • 14. [The use and utility of multistage models of carcinogenesis in cohort studies].
    Piolatto G, Pira E, Meliga F.
    Med Lav; 1994 Feb; 85(1):78-83. PubMed ID: 8035749
    [Abstract] [Full Text] [Related]

  • 15. Parameter estimation for multistage clonal expansion models from cancer incidence data: A practical identifiability analysis.
    Brouwer AF, Meza R, Eisenberg MC.
    PLoS Comput Biol; 2017 Mar; 13(3):e1005431. PubMed ID: 28288156
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hormones and multistage carcinogenesis.
    Moolgavkar SH.
    Cancer Surv; 1986 Mar; 5(3):635-48. PubMed ID: 3107813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.